Project
Illumina Body Map 2: averaged replicates
Navigation
Downloads
Results for SMAD4
Z-value: 3.46
Motif logo
Transcription factors associated with SMAD4
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
SMAD4
|
ENSG00000141646.9 | SMAD family member 4 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| SMAD4 | hg19_v2_chr18_+_48556470_48556640 | -0.10 | 5.9e-01 | Click! |
Activity profile of SMAD4 motif
Sorted Z-values of SMAD4 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr22_+_23247030 | 9.43 |
ENST00000390324.2
|
IGLJ3
|
immunoglobulin lambda joining 3 |
| chr22_+_22735135 | 7.28 |
ENST00000390297.2
|
IGLV1-44
|
immunoglobulin lambda variable 1-44 |
| chr22_+_22712087 | 6.97 |
ENST00000390294.2
|
IGLV1-47
|
immunoglobulin lambda variable 1-47 |
| chr22_+_23063100 | 6.93 |
ENST00000390309.2
|
IGLV3-19
|
immunoglobulin lambda variable 3-19 |
| chr9_-_34691201 | 6.87 |
ENST00000378800.3
ENST00000311925.2 |
CCL19
|
chemokine (C-C motif) ligand 19 |
| chr2_-_85890569 | 6.36 |
ENST00000494165.1
|
SFTPB
|
surfactant protein B |
| chr10_-_73848531 | 6.15 |
ENST00000373109.2
|
SPOCK2
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 |
| chr22_+_22676808 | 5.80 |
ENST00000390290.2
|
IGLV1-51
|
immunoglobulin lambda variable 1-51 |
| chr14_-_106878083 | 5.42 |
ENST00000390619.2
|
IGHV4-39
|
immunoglobulin heavy variable 4-39 |
| chr14_-_106209368 | 5.31 |
ENST00000390548.2
ENST00000390549.2 ENST00000390542.2 |
IGHG1
|
immunoglobulin heavy constant gamma 1 (G1m marker) |
| chr22_+_23029188 | 5.31 |
ENST00000390305.2
|
IGLV3-25
|
immunoglobulin lambda variable 3-25 |
| chr22_+_22681656 | 5.06 |
ENST00000390291.2
|
IGLV1-50
|
immunoglobulin lambda variable 1-50 (non-functional) |
| chr14_-_106725723 | 5.02 |
ENST00000390609.2
|
IGHV3-23
|
immunoglobulin heavy variable 3-23 |
| chr2_+_90229045 | 4.91 |
ENST00000390278.2
|
IGKV1D-42
|
immunoglobulin kappa variable 1D-42 (non-functional) |
| chr10_+_81370689 | 4.83 |
ENST00000372308.3
ENST00000398636.3 ENST00000428376.2 ENST00000372313.5 ENST00000419470.2 ENST00000429958.1 ENST00000439264.1 |
SFTPA1
|
surfactant protein A1 |
| chr2_-_89513402 | 4.73 |
ENST00000498435.1
|
IGKV1-27
|
immunoglobulin kappa variable 1-27 |
| chr19_-_15575369 | 4.65 |
ENST00000343625.7
|
RASAL3
|
RAS protein activator like 3 |
| chr22_+_22764088 | 4.64 |
ENST00000390299.2
|
IGLV1-40
|
immunoglobulin lambda variable 1-40 |
| chr1_+_27668505 | 4.62 |
ENST00000318074.5
|
SYTL1
|
synaptotagmin-like 1 |
| chr2_+_89901292 | 4.59 |
ENST00000448155.2
|
IGKV1D-39
|
immunoglobulin kappa variable 1D-39 |
| chr2_-_89568263 | 4.13 |
ENST00000473726.1
|
IGKV1-33
|
immunoglobulin kappa variable 1-33 |
| chr14_-_107131560 | 4.09 |
ENST00000390632.2
|
IGHV3-66
|
immunoglobulin heavy variable 3-66 |
| chr2_+_90153696 | 4.06 |
ENST00000417279.2
|
IGKV3D-15
|
immunoglobulin kappa variable 3D-15 (gene/pseudogene) |
| chr16_+_32077386 | 4.05 |
ENST00000354689.6
|
IGHV3OR16-9
|
immunoglobulin heavy variable 3/OR16-9 (non-functional) |
| chr14_-_106816253 | 4.00 |
ENST00000390615.2
|
IGHV3-33
|
immunoglobulin heavy variable 3-33 |
| chr11_-_118213455 | 3.99 |
ENST00000300692.4
|
CD3D
|
CD3d molecule, delta (CD3-TCR complex) |
| chr6_-_32731243 | 3.95 |
ENST00000427449.1
ENST00000411527.1 |
HLA-DQB2
|
major histocompatibility complex, class II, DQ beta 2 |
| chr2_-_89417335 | 3.90 |
ENST00000490686.1
|
IGKV1-17
|
immunoglobulin kappa variable 1-17 |
| chr14_-_106552755 | 3.87 |
ENST00000390600.2
|
IGHV3-9
|
immunoglobulin heavy variable 3-9 |
| chr6_-_32731299 | 3.71 |
ENST00000435145.2
ENST00000437316.2 |
HLA-DQB2
|
major histocompatibility complex, class II, DQ beta 2 |
| chr9_-_37034028 | 3.69 |
ENST00000520281.1
ENST00000446742.1 ENST00000522003.1 ENST00000523145.1 ENST00000414447.1 ENST00000377847.2 ENST00000377853.2 ENST00000377852.2 ENST00000523241.1 ENST00000520154.1 ENST00000358127.4 |
PAX5
|
paired box 5 |
| chr14_-_106830057 | 3.68 |
ENST00000390616.2
|
IGHV4-34
|
immunoglobulin heavy variable 4-34 |
| chr14_-_106406090 | 3.67 |
ENST00000390593.2
|
IGHV6-1
|
immunoglobulin heavy variable 6-1 |
| chr22_+_22786288 | 3.64 |
ENST00000390301.2
|
IGLV1-36
|
immunoglobulin lambda variable 1-36 |
| chr2_+_89184868 | 3.64 |
ENST00000390243.2
|
IGKV4-1
|
immunoglobulin kappa variable 4-1 |
| chr10_-_73848764 | 3.63 |
ENST00000317376.4
ENST00000412663.1 |
SPOCK2
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 |
| chr22_+_23077065 | 3.62 |
ENST00000390310.2
|
IGLV2-18
|
immunoglobulin lambda variable 2-18 |
| chr19_-_44285401 | 3.62 |
ENST00000262888.3
|
KCNN4
|
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
| chr14_-_106237742 | 3.56 |
ENST00000390551.2
|
IGHG3
|
immunoglobulin heavy constant gamma 3 (G3m marker) |
| chr2_-_89161064 | 3.52 |
ENST00000390241.2
|
IGKJ2
|
immunoglobulin kappa joining 2 |
| chr22_+_22930626 | 3.46 |
ENST00000390302.2
|
IGLV2-33
|
immunoglobulin lambda variable 2-33 (non-functional) |
| chr14_-_106668095 | 3.42 |
ENST00000390606.2
|
IGHV3-20
|
immunoglobulin heavy variable 3-20 |
| chr22_+_22385332 | 3.37 |
ENST00000390282.2
|
IGLV4-69
|
immunoglobulin lambda variable 4-69 |
| chr1_+_32827759 | 3.36 |
ENST00000373534.3
|
TSSK3
|
testis-specific serine kinase 3 |
| chr15_+_81071684 | 3.34 |
ENST00000220244.3
ENST00000394685.3 ENST00000356249.5 |
KIAA1199
|
KIAA1199 |
| chr1_-_44482979 | 3.28 |
ENST00000360584.2
ENST00000357730.2 ENST00000528803.1 |
SLC6A9
|
solute carrier family 6 (neurotransmitter transporter, glycine), member 9 |
| chr22_+_23089870 | 3.26 |
ENST00000390311.2
|
IGLV3-16
|
immunoglobulin lambda variable 3-16 |
| chr11_-_118213360 | 3.24 |
ENST00000529594.1
|
CD3D
|
CD3d molecule, delta (CD3-TCR complex) |
| chr19_-_42636617 | 3.23 |
ENST00000529067.1
ENST00000529952.1 ENST00000533720.1 ENST00000389341.5 ENST00000342301.4 |
POU2F2
|
POU class 2 homeobox 2 |
| chr2_-_158295915 | 3.13 |
ENST00000418920.1
|
CYTIP
|
cytohesin 1 interacting protein |
| chr14_-_106994333 | 3.11 |
ENST00000390624.2
|
IGHV3-48
|
immunoglobulin heavy variable 3-48 |
| chr1_+_32739733 | 3.10 |
ENST00000333070.4
|
LCK
|
lymphocyte-specific protein tyrosine kinase |
| chr2_-_158345462 | 3.07 |
ENST00000439355.1
ENST00000540637.1 |
CYTIP
|
cytohesin 1 interacting protein |
| chrX_-_48328631 | 2.96 |
ENST00000429543.1
ENST00000317669.5 |
SLC38A5
|
solute carrier family 38, member 5 |
| chr2_+_89923550 | 2.95 |
ENST00000509129.1
|
IGKV1D-37
|
immunoglobulin kappa variable 1D-37 (non-functional) |
| chr2_-_89459813 | 2.94 |
ENST00000390256.2
|
IGKV6-21
|
immunoglobulin kappa variable 6-21 (non-functional) |
| chr1_-_153538292 | 2.94 |
ENST00000497140.1
ENST00000368708.3 |
S100A2
|
S100 calcium binding protein A2 |
| chr11_+_117070037 | 2.88 |
ENST00000392951.4
ENST00000525531.1 ENST00000278968.6 |
TAGLN
|
transgelin |
| chr19_-_17958771 | 2.88 |
ENST00000534444.1
|
JAK3
|
Janus kinase 3 |
| chr1_+_32739714 | 2.84 |
ENST00000461712.2
ENST00000373562.3 ENST00000477031.2 ENST00000373557.2 |
LCK
|
lymphocyte-specific protein tyrosine kinase |
| chr16_+_33020496 | 2.84 |
ENST00000565407.2
|
IGHV3OR16-8
|
immunoglobulin heavy variable 3/OR16-8 (non-functional) |
| chr19_+_17638059 | 2.83 |
ENST00000599164.1
ENST00000449408.2 ENST00000600871.1 ENST00000599124.1 |
FAM129C
|
family with sequence similarity 129, member C |
| chr7_-_142247606 | 2.82 |
ENST00000390361.3
|
TRBV7-3
|
T cell receptor beta variable 7-3 |
| chr17_-_61777459 | 2.79 |
ENST00000578993.1
ENST00000583211.1 ENST00000259006.3 |
LIMD2
|
LIM domain containing 2 |
| chr6_+_32709119 | 2.78 |
ENST00000374940.3
|
HLA-DQA2
|
major histocompatibility complex, class II, DQ alpha 2 |
| chr14_-_91720224 | 2.76 |
ENST00000238699.3
ENST00000531499.2 |
GPR68
|
G protein-coupled receptor 68 |
| chr22_+_23241661 | 2.73 |
ENST00000390322.2
|
IGLJ2
|
immunoglobulin lambda joining 2 |
| chr11_+_60869980 | 2.72 |
ENST00000544014.1
|
CD5
|
CD5 molecule |
| chr2_-_89160770 | 2.61 |
ENST00000390240.2
|
IGKJ3
|
immunoglobulin kappa joining 3 |
| chr2_+_90458201 | 2.61 |
ENST00000603238.1
|
CH17-132F21.1
|
Uncharacterized protein |
| chr2_-_89340242 | 2.61 |
ENST00000480492.1
|
IGKV1-12
|
immunoglobulin kappa variable 1-12 |
| chr4_-_74847800 | 2.60 |
ENST00000296029.3
|
PF4
|
platelet factor 4 |
| chr11_+_60869867 | 2.60 |
ENST00000347785.3
|
CD5
|
CD5 molecule |
| chr2_-_89161432 | 2.57 |
ENST00000390242.2
|
IGKJ1
|
immunoglobulin kappa joining 1 |
| chr7_-_142511084 | 2.57 |
ENST00000417977.2
|
TRBV30
|
T cell receptor beta variable 30 (gene/pseudogene) |
| chrX_-_48328551 | 2.52 |
ENST00000376876.3
|
SLC38A5
|
solute carrier family 38, member 5 |
| chr9_+_136399929 | 2.50 |
ENST00000393060.1
|
ADAMTSL2
|
ADAMTS-like 2 |
| chr1_-_160681593 | 2.49 |
ENST00000368045.3
ENST00000368046.3 |
CD48
|
CD48 molecule |
| chr8_+_22019168 | 2.49 |
ENST00000318561.3
ENST00000521315.1 ENST00000437090.2 ENST00000520605.1 ENST00000522109.1 ENST00000524255.1 ENST00000523296.1 ENST00000518615.1 |
SFTPC
|
surfactant protein C |
| chr2_-_112237835 | 2.47 |
ENST00000442293.1
ENST00000439494.1 |
MIR4435-1HG
|
MIR4435-1 host gene (non-protein coding) |
| chr1_-_31230650 | 2.47 |
ENST00000294507.3
|
LAPTM5
|
lysosomal protein transmembrane 5 |
| chr22_+_22569155 | 2.44 |
ENST00000390287.2
|
IGLV10-54
|
immunoglobulin lambda variable 10-54 |
| chr1_+_159175201 | 2.44 |
ENST00000368121.2
|
DARC
|
Duffy blood group, atypical chemokine receptor |
| chr2_-_242801031 | 2.43 |
ENST00000334409.5
|
PDCD1
|
programmed cell death 1 |
| chr6_+_116937636 | 2.43 |
ENST00000368581.4
ENST00000229554.5 ENST00000368580.4 |
RSPH4A
|
radial spoke head 4 homolog A (Chlamydomonas) |
| chr7_+_142829162 | 2.42 |
ENST00000291009.3
|
PIP
|
prolactin-induced protein |
| chr19_+_17638041 | 2.40 |
ENST00000601861.1
|
FAM129C
|
family with sequence similarity 129, member C |
| chr1_+_159141397 | 2.40 |
ENST00000368124.4
ENST00000368125.4 ENST00000416746.1 |
CADM3
|
cell adhesion molecule 3 |
| chr10_-_81708854 | 2.35 |
ENST00000372292.3
|
SFTPD
|
surfactant protein D |
| chr1_-_207095212 | 2.34 |
ENST00000420007.2
|
FAIM3
|
Fas apoptotic inhibitory molecule 3 |
| chr19_-_42636543 | 2.31 |
ENST00000528894.4
ENST00000560804.2 ENST00000560558.1 ENST00000560398.1 ENST00000526816.2 |
POU2F2
|
POU class 2 homeobox 2 |
| chr19_-_17958832 | 2.28 |
ENST00000458235.1
|
JAK3
|
Janus kinase 3 |
| chr19_+_49055332 | 2.25 |
ENST00000201586.2
|
SULT2B1
|
sulfotransferase family, cytosolic, 2B, member 1 |
| chr14_-_106330458 | 2.25 |
ENST00000461719.1
|
IGHJ4
|
immunoglobulin heavy joining 4 |
| chr2_-_85895295 | 2.19 |
ENST00000428225.1
ENST00000519937.2 |
SFTPB
|
surfactant protein B |
| chr16_+_2880369 | 2.19 |
ENST00000572863.1
|
ZG16B
|
zymogen granule protein 16B |
| chr20_+_57766075 | 2.16 |
ENST00000371030.2
|
ZNF831
|
zinc finger protein 831 |
| chr15_-_20193370 | 2.14 |
ENST00000558565.2
|
IGHV3OR15-7
|
immunoglobulin heavy variable 3/OR15-7 (pseudogene) |
| chr22_+_23213658 | 2.13 |
ENST00000390318.2
|
IGLV4-3
|
immunoglobulin lambda variable 4-3 |
| chr17_+_41003166 | 2.11 |
ENST00000308423.2
|
AOC3
|
amine oxidase, copper containing 3 |
| chr2_+_177025619 | 2.11 |
ENST00000410016.1
|
HOXD3
|
homeobox D3 |
| chr7_+_142028105 | 2.10 |
ENST00000390353.2
|
TRBV6-1
|
T cell receptor beta variable 6-1 |
| chr19_-_43032532 | 2.05 |
ENST00000403461.1
ENST00000352591.5 ENST00000358394.3 ENST00000403444.3 ENST00000308072.4 ENST00000599389.1 ENST00000351134.3 ENST00000161559.6 |
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) |
| chr22_+_22707260 | 2.05 |
ENST00000390293.1
|
IGLV5-48
|
immunoglobulin lambda variable 5-48 (non-functional) |
| chr8_+_104383728 | 2.05 |
ENST00000330295.5
|
CTHRC1
|
collagen triple helix repeat containing 1 |
| chr8_+_104383759 | 2.04 |
ENST00000415886.2
|
CTHRC1
|
collagen triple helix repeat containing 1 |
| chr15_-_74726283 | 2.03 |
ENST00000543145.2
|
SEMA7A
|
semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group) |
| chr10_-_73848086 | 2.02 |
ENST00000536168.1
|
SPOCK2
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 |
| chr14_+_22309368 | 2.02 |
ENST00000390433.1
|
TRAV12-1
|
T cell receptor alpha variable 12-1 |
| chr19_-_14629224 | 2.02 |
ENST00000254322.2
|
DNAJB1
|
DnaJ (Hsp40) homolog, subfamily B, member 1 |
| chr14_+_22320634 | 2.00 |
ENST00000390435.1
|
TRAV8-3
|
T cell receptor alpha variable 8-3 |
| chr16_-_33647696 | 1.98 |
ENST00000558425.1
ENST00000569103.2 |
RP11-812E19.9
|
Uncharacterized protein |
| chr12_-_57871825 | 1.98 |
ENST00000548139.1
|
ARHGAP9
|
Rho GTPase activating protein 9 |
| chr12_-_57871853 | 1.97 |
ENST00000549602.1
ENST00000430041.2 |
ARHGAP9
|
Rho GTPase activating protein 9 |
| chr14_+_22771851 | 1.97 |
ENST00000390466.1
|
TRAV39
|
T cell receptor alpha variable 39 |
| chr4_+_71384257 | 1.96 |
ENST00000339336.4
|
AMTN
|
amelotin |
| chr19_-_11688447 | 1.96 |
ENST00000590420.1
|
ACP5
|
acid phosphatase 5, tartrate resistant |
| chr11_-_118213331 | 1.96 |
ENST00000392884.2
|
CD3D
|
CD3d molecule, delta (CD3-TCR complex) |
| chr15_+_49715293 | 1.93 |
ENST00000267843.4
ENST00000560270.1 |
FGF7
|
fibroblast growth factor 7 |
| chr11_-_107729887 | 1.93 |
ENST00000525815.1
|
SLC35F2
|
solute carrier family 35, member F2 |
| chr14_+_22362613 | 1.92 |
ENST00000390438.2
|
TRAV8-4
|
T cell receptor alpha variable 8-4 |
| chr12_-_15103621 | 1.91 |
ENST00000536592.1
|
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta |
| chr12_-_9913489 | 1.91 |
ENST00000228434.3
ENST00000536709.1 |
CD69
|
CD69 molecule |
| chr1_-_207095324 | 1.90 |
ENST00000530505.1
ENST00000367091.3 ENST00000442471.2 |
FAIM3
|
Fas apoptotic inhibitory molecule 3 |
| chr1_+_26485511 | 1.90 |
ENST00000374268.3
|
FAM110D
|
family with sequence similarity 110, member D |
| chr19_-_41859814 | 1.90 |
ENST00000221930.5
|
TGFB1
|
transforming growth factor, beta 1 |
| chr1_+_26869597 | 1.89 |
ENST00000530003.1
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1 |
| chr19_+_11649532 | 1.89 |
ENST00000252456.2
ENST00000592923.1 ENST00000535659.2 |
CNN1
|
calponin 1, basic, smooth muscle |
| chr5_-_121413974 | 1.89 |
ENST00000231004.4
|
LOX
|
lysyl oxidase |
| chr15_+_49715449 | 1.89 |
ENST00000560979.1
|
FGF7
|
fibroblast growth factor 7 |
| chr19_-_54784353 | 1.88 |
ENST00000391746.1
|
LILRB2
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 |
| chr7_+_142448053 | 1.88 |
ENST00000422143.2
|
TRBV29-1
|
T cell receptor beta variable 29-1 |
| chr2_-_85108164 | 1.88 |
ENST00000409520.2
|
TRABD2A
|
TraB domain containing 2A |
| chr1_+_203734296 | 1.87 |
ENST00000442561.2
ENST00000367217.5 |
LAX1
|
lymphocyte transmembrane adaptor 1 |
| chr2_-_85108363 | 1.87 |
ENST00000335459.5
|
TRABD2A
|
TraB domain containing 2A |
| chr14_+_22739823 | 1.85 |
ENST00000390464.2
|
TRAV38-1
|
T cell receptor alpha variable 38-1 |
| chr1_-_153522562 | 1.85 |
ENST00000368714.1
|
S100A4
|
S100 calcium binding protein A4 |
| chr19_-_11688500 | 1.84 |
ENST00000433365.2
|
ACP5
|
acid phosphatase 5, tartrate resistant |
| chr13_+_102104952 | 1.83 |
ENST00000376180.3
|
ITGBL1
|
integrin, beta-like 1 (with EGF-like repeat domains) |
| chr7_-_139727118 | 1.83 |
ENST00000484111.1
|
PARP12
|
poly (ADP-ribose) polymerase family, member 12 |
| chr16_+_9056563 | 1.83 |
ENST00000564485.1
|
RP11-77H9.8
|
RP11-77H9.8 |
| chr8_+_104384616 | 1.82 |
ENST00000520337.1
|
CTHRC1
|
collagen triple helix repeat containing 1 |
| chr1_-_32827682 | 1.79 |
ENST00000432622.1
|
FAM229A
|
family with sequence similarity 229, member A |
| chr19_+_46171464 | 1.79 |
ENST00000590918.1
ENST00000263281.3 ENST00000304207.8 |
GIPR
|
gastric inhibitory polypeptide receptor |
| chr1_-_202129704 | 1.77 |
ENST00000476061.1
ENST00000544762.1 ENST00000467283.1 ENST00000464870.1 ENST00000435759.2 ENST00000486116.1 ENST00000543735.1 ENST00000308986.5 ENST00000477625.1 |
PTPN7
|
protein tyrosine phosphatase, non-receptor type 7 |
| chr19_-_54784937 | 1.77 |
ENST00000434421.1
ENST00000314446.5 ENST00000391749.4 |
LILRB2
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 |
| chr12_-_53594227 | 1.75 |
ENST00000550743.2
|
ITGB7
|
integrin, beta 7 |
| chr12_-_7281469 | 1.74 |
ENST00000542370.1
ENST00000266560.3 |
RBP5
|
retinol binding protein 5, cellular |
| chr1_-_59249732 | 1.74 |
ENST00000371222.2
|
JUN
|
jun proto-oncogene |
| chr1_-_160492994 | 1.73 |
ENST00000368055.1
ENST00000368057.3 ENST00000368059.3 |
SLAMF6
|
SLAM family member 6 |
| chr4_-_13546632 | 1.71 |
ENST00000382438.5
|
NKX3-2
|
NK3 homeobox 2 |
| chr11_+_60739115 | 1.71 |
ENST00000344028.5
ENST00000346437.4 |
CD6
|
CD6 molecule |
| chr12_-_15104040 | 1.71 |
ENST00000541644.1
ENST00000545895.1 |
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta |
| chr2_+_87769459 | 1.70 |
ENST00000414030.1
ENST00000437561.1 |
LINC00152
|
long intergenic non-protein coding RNA 152 |
| chr4_+_25657444 | 1.70 |
ENST00000504570.1
ENST00000382051.3 |
SLC34A2
|
solute carrier family 34 (type II sodium/phosphate contransporter), member 2 |
| chr12_-_57872336 | 1.69 |
ENST00000552066.1
|
ARHGAP9
|
Rho GTPase activating protein 9 |
| chr19_+_49838653 | 1.68 |
ENST00000598095.1
ENST00000426897.2 ENST00000323906.4 ENST00000535669.2 ENST00000597602.1 ENST00000595660.1 |
CD37
|
CD37 molecule |
| chrX_-_70326455 | 1.68 |
ENST00000374251.5
|
CXorf65
|
chromosome X open reading frame 65 |
| chr9_-_117150243 | 1.68 |
ENST00000374088.3
|
AKNA
|
AT-hook transcription factor |
| chr9_-_113342160 | 1.67 |
ENST00000401783.2
ENST00000374461.1 |
SVEP1
|
sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1 |
| chr19_-_54824344 | 1.67 |
ENST00000346508.3
ENST00000446712.3 ENST00000432233.3 ENST00000301219.3 |
LILRA5
|
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5 |
| chr19_-_51529849 | 1.66 |
ENST00000600362.1
ENST00000453757.3 ENST00000601671.1 |
KLK11
|
kallikrein-related peptidase 11 |
| chr9_-_113341985 | 1.64 |
ENST00000374469.1
|
SVEP1
|
sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1 |
| chr19_-_47287990 | 1.64 |
ENST00000593713.1
ENST00000598022.1 ENST00000434726.2 |
SLC1A5
|
solute carrier family 1 (neutral amino acid transporter), member 5 |
| chr19_-_54984354 | 1.64 |
ENST00000301200.2
|
CDC42EP5
|
CDC42 effector protein (Rho GTPase binding) 5 |
| chr1_-_157670647 | 1.64 |
ENST00000368184.3
|
FCRL3
|
Fc receptor-like 3 |
| chr2_-_158345341 | 1.63 |
ENST00000435117.1
|
CYTIP
|
cytohesin 1 interacting protein |
| chr4_+_74718906 | 1.61 |
ENST00000226524.3
|
PF4V1
|
platelet factor 4 variant 1 |
| chr15_+_81591757 | 1.60 |
ENST00000558332.1
|
IL16
|
interleukin 16 |
| chr12_-_48213568 | 1.59 |
ENST00000080059.7
ENST00000354334.3 ENST00000430670.1 ENST00000552960.1 ENST00000440293.1 |
HDAC7
|
histone deacetylase 7 |
| chr11_-_107729287 | 1.59 |
ENST00000375682.4
|
SLC35F2
|
solute carrier family 35, member F2 |
| chr1_-_44497024 | 1.58 |
ENST00000372306.3
ENST00000372310.3 ENST00000475075.2 |
SLC6A9
|
solute carrier family 6 (neurotransmitter transporter, glycine), member 9 |
| chr1_-_160832642 | 1.57 |
ENST00000368034.4
|
CD244
|
CD244 molecule, natural killer cell receptor 2B4 |
| chr12_-_11463353 | 1.57 |
ENST00000279575.1
ENST00000535904.1 ENST00000445719.2 |
PRB4
|
proline-rich protein BstNI subfamily 4 |
| chr11_+_45943169 | 1.57 |
ENST00000529052.1
ENST00000531526.1 |
GYLTL1B
|
glycosyltransferase-like 1B |
| chr19_+_7413835 | 1.57 |
ENST00000576789.1
|
CTB-133G6.1
|
CTB-133G6.1 |
| chrX_+_48542168 | 1.56 |
ENST00000376701.4
|
WAS
|
Wiskott-Aldrich syndrome |
| chr1_-_153538011 | 1.56 |
ENST00000368707.4
|
S100A2
|
S100 calcium binding protein A2 |
| chr1_-_161168834 | 1.56 |
ENST00000367995.3
ENST00000367996.5 |
ADAMTS4
|
ADAM metallopeptidase with thrombospondin type 1 motif, 4 |
| chr1_-_160832490 | 1.55 |
ENST00000322302.7
ENST00000368033.3 |
CD244
|
CD244 molecule, natural killer cell receptor 2B4 |
| chr12_+_54384370 | 1.55 |
ENST00000504315.1
|
HOXC6
|
homeobox C6 |
| chr11_+_67171548 | 1.53 |
ENST00000542590.1
|
TBC1D10C
|
TBC1 domain family, member 10C |
| chr19_+_41949054 | 1.53 |
ENST00000378187.2
|
C19orf69
|
chromosome 19 open reading frame 69 |
| chr2_+_30454390 | 1.52 |
ENST00000395323.3
ENST00000406087.1 ENST00000404397.1 |
LBH
|
limb bud and heart development |
| chr6_-_32908765 | 1.51 |
ENST00000416244.2
|
HLA-DMB
|
major histocompatibility complex, class II, DM beta |
| chr7_+_94023873 | 1.50 |
ENST00000297268.6
|
COL1A2
|
collagen, type I, alpha 2 |
| chrX_-_119445306 | 1.49 |
ENST00000371369.4
ENST00000440464.1 ENST00000519908.1 |
TMEM255A
|
transmembrane protein 255A |
| chr1_+_27669719 | 1.49 |
ENST00000473280.1
|
SYTL1
|
synaptotagmin-like 1 |
| chr12_+_52445191 | 1.48 |
ENST00000243050.1
ENST00000394825.1 ENST00000550763.1 ENST00000394824.2 ENST00000548232.1 ENST00000562373.1 |
NR4A1
|
nuclear receptor subfamily 4, group A, member 1 |
| chr4_+_166794383 | 1.48 |
ENST00000061240.2
ENST00000507499.1 |
TLL1
|
tolloid-like 1 |
| chr13_+_102104980 | 1.48 |
ENST00000545560.2
|
ITGBL1
|
integrin, beta-like 1 (with EGF-like repeat domains) |
| chr1_+_26348259 | 1.48 |
ENST00000374280.3
|
EXTL1
|
exostosin-like glycosyltransferase 1 |
| chr16_+_2880157 | 1.47 |
ENST00000382280.3
|
ZG16B
|
zymogen granule protein 16B |
| chr12_-_11422739 | 1.47 |
ENST00000279573.7
|
PRB3
|
proline-rich protein BstNI subfamily 3 |
| chr12_+_104982622 | 1.46 |
ENST00000549016.1
|
CHST11
|
carbohydrate (chondroitin 4) sulfotransferase 11 |
| chr5_-_168727786 | 1.45 |
ENST00000332966.8
|
SLIT3
|
slit homolog 3 (Drosophila) |
| chr11_-_64612041 | 1.44 |
ENST00000342711.5
|
CDC42BPG
|
CDC42 binding protein kinase gamma (DMPK-like) |
| chr5_-_168728103 | 1.44 |
ENST00000519560.1
|
SLIT3
|
slit homolog 3 (Drosophila) |
| chr12_+_54519842 | 1.44 |
ENST00000508564.1
|
RP11-834C11.4
|
RP11-834C11.4 |
| chr7_-_45018686 | 1.43 |
ENST00000258787.7
|
MYO1G
|
myosin IG |
Network of associatons between targets according to the STRING database.
First level regulatory network of SMAD4
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.3 | 6.9 | GO:2000547 | regulation of dendritic cell dendrite assembly(GO:2000547) |
| 2.1 | 6.2 | GO:0061536 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 1.7 | 5.2 | GO:0045210 | negative regulation of dendritic cell cytokine production(GO:0002731) FasL biosynthetic process(GO:0045210) |
| 1.3 | 1.3 | GO:1902214 | regulation of interleukin-4-mediated signaling pathway(GO:1902214) |
| 1.3 | 3.8 | GO:0061033 | secretion by lung epithelial cell involved in lung growth(GO:0061033) |
| 1.2 | 4.9 | GO:1904808 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 1.0 | 3.1 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
| 1.0 | 7.8 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
| 0.9 | 3.8 | GO:0071663 | granzyme B production(GO:0071613) regulation of granzyme B production(GO:0071661) positive regulation of granzyme B production(GO:0071663) |
| 0.9 | 2.6 | GO:0070175 | positive regulation of enamel mineralization(GO:0070175) |
| 0.8 | 2.4 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
| 0.8 | 2.4 | GO:2001190 | positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001190) |
| 0.8 | 3.2 | GO:0036229 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.8 | 4.7 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
| 0.8 | 2.3 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
| 0.7 | 4.3 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
| 0.7 | 5.5 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
| 0.7 | 2.1 | GO:0043317 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) regulation of cytotoxic T cell degranulation(GO:0043317) negative regulation of cytotoxic T cell degranulation(GO:0043318) |
| 0.6 | 109.9 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 0.6 | 1.2 | GO:0070662 | mast cell proliferation(GO:0070662) |
| 0.6 | 9.7 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
| 0.6 | 2.4 | GO:0006218 | uridine catabolic process(GO:0006218) |
| 0.6 | 1.7 | GO:0061713 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
| 0.6 | 2.2 | GO:0000103 | sulfate assimilation(GO:0000103) |
| 0.5 | 4.4 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 0.5 | 0.5 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
| 0.5 | 3.6 | GO:0071461 | cellular response to redox state(GO:0071461) |
| 0.5 | 12.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.5 | 0.5 | GO:0071231 | cellular response to folic acid(GO:0071231) |
| 0.5 | 2.0 | GO:0030185 | nitric oxide transport(GO:0030185) |
| 0.5 | 1.5 | GO:0033037 | polysaccharide localization(GO:0033037) |
| 0.5 | 1.0 | GO:0046102 | inosine metabolic process(GO:0046102) |
| 0.5 | 1.4 | GO:0043315 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
| 0.5 | 1.4 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 0.5 | 3.6 | GO:2000035 | regulation of stem cell division(GO:2000035) |
| 0.4 | 2.2 | GO:0072023 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
| 0.4 | 1.3 | GO:0042489 | negative regulation of odontogenesis of dentin-containing tooth(GO:0042489) |
| 0.4 | 3.5 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
| 0.4 | 2.6 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
| 0.4 | 3.4 | GO:0072277 | metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
| 0.4 | 9.3 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.4 | 6.4 | GO:0015816 | glycine transport(GO:0015816) |
| 0.4 | 2.9 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.4 | 2.9 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.4 | 1.2 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) positive regulation of somatostatin secretion(GO:0090274) |
| 0.4 | 1.2 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
| 0.4 | 2.3 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.4 | 1.6 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
| 0.4 | 1.2 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.4 | 1.1 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.4 | 1.5 | GO:0032690 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
| 0.4 | 1.8 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.3 | 2.1 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) abortive mitotic cell cycle(GO:0033277) |
| 0.3 | 2.4 | GO:0043163 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 0.3 | 1.3 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
| 0.3 | 1.0 | GO:0086044 | atrial ventricular junction remodeling(GO:0003294) atrial cardiac muscle cell to AV node cell communication by electrical coupling(GO:0086044) bundle of His cell to Purkinje myocyte communication by electrical coupling(GO:0086054) Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling(GO:0086055) regulation of Purkinje myocyte action potential(GO:0098906) vasomotion(GO:1990029) |
| 0.3 | 0.6 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
| 0.3 | 0.9 | GO:1990654 | sebum secreting cell proliferation(GO:1990654) |
| 0.3 | 0.9 | GO:2000452 | CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) positive regulation of necroptotic process(GO:0060545) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
| 0.3 | 0.9 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
| 0.3 | 2.8 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.3 | 0.9 | GO:1901202 | negative regulation of extracellular matrix assembly(GO:1901202) |
| 0.3 | 0.9 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
| 0.3 | 4.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 0.3 | 1.2 | GO:0035397 | helper T cell enhancement of adaptive immune response(GO:0035397) |
| 0.3 | 2.1 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
| 0.3 | 4.2 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.3 | 0.3 | GO:0051135 | positive regulation of NK T cell activation(GO:0051135) |
| 0.3 | 2.3 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.3 | 2.9 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
| 0.3 | 1.7 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
| 0.3 | 0.9 | GO:0072356 | chromosome passenger complex localization to kinetochore(GO:0072356) |
| 0.3 | 0.9 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
| 0.3 | 1.1 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
| 0.3 | 2.0 | GO:0014028 | notochord formation(GO:0014028) |
| 0.3 | 1.1 | GO:0019417 | sulfur oxidation(GO:0019417) |
| 0.3 | 0.5 | GO:0061010 | gall bladder development(GO:0061010) |
| 0.3 | 1.1 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 0.3 | 0.8 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.3 | 1.3 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
| 0.3 | 0.8 | GO:0060557 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
| 0.3 | 1.3 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.3 | 2.3 | GO:0072144 | glomerular mesangial cell development(GO:0072144) |
| 0.3 | 2.0 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 0.3 | 54.6 | GO:0002377 | immunoglobulin production(GO:0002377) |
| 0.2 | 0.7 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
| 0.2 | 1.0 | GO:0016267 | O-glycan processing, core 1(GO:0016267) |
| 0.2 | 1.0 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
| 0.2 | 0.7 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
| 0.2 | 1.0 | GO:0061743 | motor learning(GO:0061743) |
| 0.2 | 2.4 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
| 0.2 | 0.7 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
| 0.2 | 0.9 | GO:0002432 | granuloma formation(GO:0002432) |
| 0.2 | 2.1 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 0.2 | 0.7 | GO:1990637 | response to prolactin(GO:1990637) regulation of ovarian follicle development(GO:2000354) |
| 0.2 | 0.7 | GO:0002582 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 0.2 | 0.7 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.2 | 0.9 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
| 0.2 | 0.8 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
| 0.2 | 1.0 | GO:0042488 | positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) |
| 0.2 | 1.2 | GO:0042335 | cuticle development(GO:0042335) |
| 0.2 | 4.2 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
| 0.2 | 1.8 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
| 0.2 | 0.8 | GO:0001878 | response to yeast(GO:0001878) |
| 0.2 | 2.1 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
| 0.2 | 0.5 | GO:0050894 | determination of affect(GO:0050894) |
| 0.2 | 22.4 | GO:0031295 | T cell costimulation(GO:0031295) |
| 0.2 | 4.9 | GO:0045109 | intermediate filament organization(GO:0045109) |
| 0.2 | 2.6 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.2 | 1.6 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.2 | 1.0 | GO:0070221 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 0.2 | 0.8 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
| 0.2 | 0.3 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
| 0.2 | 0.5 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
| 0.2 | 3.7 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
| 0.2 | 4.3 | GO:0001771 | immunological synapse formation(GO:0001771) |
| 0.2 | 1.3 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
| 0.2 | 1.0 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 0.2 | 1.5 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.2 | 0.9 | GO:0002729 | positive regulation of natural killer cell cytokine production(GO:0002729) positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) |
| 0.2 | 1.9 | GO:0072501 | cellular divalent inorganic anion homeostasis(GO:0072501) |
| 0.2 | 0.6 | GO:0071672 | negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
| 0.2 | 2.3 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.2 | 0.6 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
| 0.2 | 0.6 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.2 | 0.6 | GO:0031133 | regulation of axon diameter(GO:0031133) |
| 0.2 | 0.5 | GO:0021722 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 0.2 | 1.4 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
| 0.1 | 0.9 | GO:0038112 | interleukin-8-mediated signaling pathway(GO:0038112) |
| 0.1 | 0.4 | GO:0051714 | regulation of cytolysis in other organism(GO:0051710) positive regulation of cytolysis in other organism(GO:0051714) |
| 0.1 | 1.3 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
| 0.1 | 1.9 | GO:0015889 | cobalt ion transport(GO:0006824) cobalamin transport(GO:0015889) |
| 0.1 | 1.7 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
| 0.1 | 2.9 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.1 | 0.7 | GO:0006051 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
| 0.1 | 2.6 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.1 | 1.1 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 0.1 | 14.5 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
| 0.1 | 1.6 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 0.1 | 0.4 | GO:0007412 | axon target recognition(GO:0007412) |
| 0.1 | 0.4 | GO:0060827 | regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
| 0.1 | 0.7 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
| 0.1 | 0.5 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) |
| 0.1 | 1.2 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 0.1 | 1.3 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
| 0.1 | 0.5 | GO:0019056 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
| 0.1 | 0.7 | GO:0010165 | response to X-ray(GO:0010165) |
| 0.1 | 2.6 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.1 | 0.6 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
| 0.1 | 0.6 | GO:0010958 | regulation of amino acid import(GO:0010958) L-arginine import(GO:0043091) arginine import(GO:0090467) |
| 0.1 | 0.4 | GO:1903925 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) negative regulation of mitotic cell cycle DNA replication(GO:1903464) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
| 0.1 | 0.6 | GO:0070384 | Harderian gland development(GO:0070384) |
| 0.1 | 0.5 | GO:0061626 | BMP signaling pathway involved in heart development(GO:0061312) pharyngeal arch artery morphogenesis(GO:0061626) |
| 0.1 | 0.5 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
| 0.1 | 0.5 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.1 | 0.2 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
| 0.1 | 0.3 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.1 | 0.8 | GO:0021553 | olfactory nerve development(GO:0021553) |
| 0.1 | 0.9 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.1 | 0.6 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.1 | 0.3 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) |
| 0.1 | 1.0 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 0.1 | 0.6 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.1 | 2.5 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
| 0.1 | 0.8 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
| 0.1 | 1.3 | GO:0021759 | globus pallidus development(GO:0021759) |
| 0.1 | 1.1 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
| 0.1 | 0.6 | GO:0060979 | vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
| 0.1 | 1.6 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
| 0.1 | 0.8 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.1 | 0.3 | GO:0033082 | extrathymic T cell differentiation(GO:0033078) regulation of extrathymic T cell differentiation(GO:0033082) |
| 0.1 | 0.2 | GO:2000669 | negative regulation of dendritic cell apoptotic process(GO:2000669) |
| 0.1 | 1.3 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.1 | 1.3 | GO:0051969 | regulation of transmission of nerve impulse(GO:0051969) |
| 0.1 | 0.7 | GO:0021699 | hindbrain maturation(GO:0021578) cerebellum maturation(GO:0021590) central nervous system maturation(GO:0021626) cerebellar cortex maturation(GO:0021699) |
| 0.1 | 1.7 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.1 | 0.4 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 0.1 | 0.6 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.1 | 1.2 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
| 0.1 | 1.1 | GO:0032264 | IMP salvage(GO:0032264) |
| 0.1 | 3.1 | GO:0097320 | membrane tubulation(GO:0097320) |
| 0.1 | 0.3 | GO:2000681 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
| 0.1 | 0.3 | GO:0031247 | actin rod assembly(GO:0031247) |
| 0.1 | 0.8 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 0.1 | 0.4 | GO:0034350 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
| 0.1 | 1.5 | GO:0043589 | skin morphogenesis(GO:0043589) |
| 0.1 | 0.8 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
| 0.1 | 0.6 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
| 0.1 | 0.3 | GO:0003169 | coronary vein morphogenesis(GO:0003169) regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
| 0.1 | 0.4 | GO:0010446 | response to alkaline pH(GO:0010446) |
| 0.1 | 7.5 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
| 0.1 | 1.0 | GO:0070307 | lens fiber cell development(GO:0070307) |
| 0.1 | 1.2 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 0.1 | 0.4 | GO:0044855 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
| 0.1 | 0.2 | GO:0098884 | postsynaptic neurotransmitter receptor internalization(GO:0098884) |
| 0.1 | 0.7 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.1 | 0.6 | GO:1905066 | arterial endothelial cell fate commitment(GO:0060844) positive regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061419) positive regulation of ephrin receptor signaling pathway(GO:1901189) regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901295) positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) regulation of canonical Wnt signaling pathway involved in heart development(GO:1905066) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
| 0.1 | 0.2 | GO:0000349 | generation of catalytic spliceosome for first transesterification step(GO:0000349) |
| 0.1 | 1.6 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
| 0.1 | 0.3 | GO:0035711 | plasmacytoid dendritic cell activation(GO:0002270) T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) regulation of restriction endodeoxyribonuclease activity(GO:0032072) T-helper 1 cell activation(GO:0035711) |
| 0.1 | 1.6 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.1 | 0.6 | GO:1902963 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
| 0.1 | 1.6 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.1 | 0.5 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
| 0.1 | 0.7 | GO:2001199 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.1 | 0.5 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 0.1 | 1.0 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) |
| 0.1 | 0.3 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
| 0.1 | 0.5 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
| 0.1 | 0.2 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
| 0.1 | 0.5 | GO:0030002 | cellular anion homeostasis(GO:0030002) cellular monovalent inorganic anion homeostasis(GO:0030320) |
| 0.1 | 1.7 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
| 0.1 | 0.2 | GO:0052314 | phytoalexin metabolic process(GO:0052314) |
| 0.1 | 0.9 | GO:0072321 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) chaperone-mediated protein transport(GO:0072321) |
| 0.1 | 0.4 | GO:0050893 | sensory processing(GO:0050893) |
| 0.1 | 0.4 | GO:0043383 | negative T cell selection(GO:0043383) |
| 0.1 | 0.2 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.1 | 0.9 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
| 0.1 | 1.1 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
| 0.1 | 0.3 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.1 | 0.3 | GO:0000354 | cis assembly of pre-catalytic spliceosome(GO:0000354) |
| 0.1 | 0.7 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
| 0.1 | 1.4 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
| 0.1 | 0.4 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 0.1 | 0.9 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.1 | 0.8 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
| 0.1 | 0.6 | GO:0030183 | B cell differentiation(GO:0030183) |
| 0.1 | 0.4 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 0.1 | 0.5 | GO:0032328 | alanine transport(GO:0032328) |
| 0.1 | 0.2 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
| 0.1 | 0.4 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
| 0.1 | 0.6 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.1 | 0.2 | GO:0006624 | vacuolar protein processing(GO:0006624) |
| 0.1 | 1.5 | GO:0022401 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
| 0.1 | 1.2 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
| 0.1 | 0.6 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
| 0.1 | 1.0 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
| 0.1 | 0.8 | GO:0030259 | lipid glycosylation(GO:0030259) |
| 0.1 | 0.3 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 0.1 | 0.2 | GO:1904106 | protein localization to microvillus(GO:1904106) |
| 0.1 | 1.0 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
| 0.1 | 0.6 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 0.1 | 0.3 | GO:0043585 | nose morphogenesis(GO:0043585) alveolar primary septum development(GO:0061143) |
| 0.1 | 0.4 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.1 | 3.4 | GO:0035082 | axoneme assembly(GO:0035082) |
| 0.1 | 0.7 | GO:0000733 | DNA strand renaturation(GO:0000733) |
| 0.1 | 0.1 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
| 0.1 | 0.5 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
| 0.0 | 1.1 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.0 | 4.5 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.0 | 1.7 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.0 | 0.3 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
| 0.0 | 0.9 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
| 0.0 | 0.7 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.0 | 0.9 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.0 | 0.2 | GO:0048266 | behavioral response to pain(GO:0048266) |
| 0.0 | 0.6 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.0 | 1.1 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
| 0.0 | 0.1 | GO:0048631 | negative regulation of skeletal muscle cell proliferation(GO:0014859) regulation of skeletal muscle tissue growth(GO:0048631) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) negative regulation of satellite cell differentiation(GO:1902725) |
| 0.0 | 0.5 | GO:0002084 | protein depalmitoylation(GO:0002084) |
| 0.0 | 0.3 | GO:0002933 | lipid hydroxylation(GO:0002933) |
| 0.0 | 0.5 | GO:0070197 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
| 0.0 | 0.3 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
| 0.0 | 2.1 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.0 | 0.8 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
| 0.0 | 0.9 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
| 0.0 | 0.8 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
| 0.0 | 1.1 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
| 0.0 | 0.2 | GO:1900111 | regulation of histone H3-K9 dimethylation(GO:1900109) positive regulation of histone H3-K9 dimethylation(GO:1900111) |
| 0.0 | 0.2 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
| 0.0 | 0.7 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
| 0.0 | 0.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
| 0.0 | 0.7 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
| 0.0 | 0.2 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
| 0.0 | 0.8 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.0 | 0.2 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
| 0.0 | 0.3 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
| 0.0 | 0.5 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
| 0.0 | 0.5 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.0 | 0.9 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
| 0.0 | 0.1 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
| 0.0 | 0.2 | GO:0035932 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
| 0.0 | 0.2 | GO:0048749 | compound eye development(GO:0048749) |
| 0.0 | 1.5 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.0 | 3.2 | GO:0031016 | pancreas development(GO:0031016) |
| 0.0 | 1.3 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.0 | 1.3 | GO:0010842 | retina layer formation(GO:0010842) |
| 0.0 | 0.2 | GO:0019348 | dolichol metabolic process(GO:0019348) |
| 0.0 | 0.4 | GO:0030252 | growth hormone secretion(GO:0030252) |
| 0.0 | 0.8 | GO:0072678 | T cell migration(GO:0072678) |
| 0.0 | 0.2 | GO:0071839 | apoptotic process in bone marrow(GO:0071839) |
| 0.0 | 0.3 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
| 0.0 | 0.6 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 0.0 | 0.6 | GO:0060155 | platelet dense granule organization(GO:0060155) |
| 0.0 | 0.7 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
| 0.0 | 0.2 | GO:1903232 | melanosome assembly(GO:1903232) |
| 0.0 | 2.1 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.0 | 0.4 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.0 | 0.9 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.0 | 2.9 | GO:0001895 | retina homeostasis(GO:0001895) |
| 0.0 | 0.1 | GO:1990736 | positive regulation of regulation of vascular smooth muscle cell membrane depolarization(GO:1904199) regulation of vascular smooth muscle cell membrane depolarization(GO:1990736) |
| 0.0 | 0.2 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
| 0.0 | 0.8 | GO:0070207 | protein homotrimerization(GO:0070207) |
| 0.0 | 1.5 | GO:1901186 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
| 0.0 | 1.2 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
| 0.0 | 0.6 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
| 0.0 | 0.6 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
| 0.0 | 0.6 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
| 0.0 | 0.3 | GO:1901739 | regulation of myoblast fusion(GO:1901739) negative regulation of myoblast fusion(GO:1901740) regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
| 0.0 | 0.2 | GO:1903859 | dendrite extension(GO:0097484) regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 0.0 | 0.1 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
| 0.0 | 0.3 | GO:0048368 | lateral mesoderm development(GO:0048368) |
| 0.0 | 1.0 | GO:0015813 | L-glutamate transport(GO:0015813) |
| 0.0 | 0.2 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
| 0.0 | 0.5 | GO:1903020 | positive regulation of glycoprotein metabolic process(GO:1903020) |
| 0.0 | 0.1 | GO:0045076 | regulation of interleukin-2 biosynthetic process(GO:0045076) |
| 0.0 | 0.6 | GO:0070831 | basement membrane assembly(GO:0070831) |
| 0.0 | 0.4 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
| 0.0 | 1.7 | GO:0050909 | sensory perception of taste(GO:0050909) |
| 0.0 | 0.9 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
| 0.0 | 0.2 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
| 0.0 | 0.7 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
| 0.0 | 0.6 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
| 0.0 | 0.1 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
| 0.0 | 0.1 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
| 0.0 | 0.3 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
| 0.0 | 1.3 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
| 0.0 | 0.8 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
| 0.0 | 0.9 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
| 0.0 | 1.6 | GO:0050672 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
| 0.0 | 0.8 | GO:0007413 | axonal fasciculation(GO:0007413) |
| 0.0 | 0.1 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.0 | 0.5 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.0 | 0.7 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
| 0.0 | 0.6 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
| 0.0 | 1.6 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
| 0.0 | 0.4 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
| 0.0 | 1.3 | GO:1903146 | regulation of mitophagy(GO:1903146) |
| 0.0 | 0.2 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.0 | 0.2 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.0 | 0.3 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
| 0.0 | 2.5 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.0 | 0.2 | GO:0043385 | mycotoxin metabolic process(GO:0043385) aflatoxin metabolic process(GO:0046222) organic heteropentacyclic compound metabolic process(GO:1901376) |
| 0.0 | 0.1 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.0 | 0.3 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.0 | 0.1 | GO:0046035 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 0.0 | 1.0 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.0 | 0.2 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.0 | 0.5 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.0 | 0.4 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
| 0.0 | 1.6 | GO:0016525 | negative regulation of angiogenesis(GO:0016525) |
| 0.0 | 0.4 | GO:0015671 | oxygen transport(GO:0015671) |
| 0.0 | 0.3 | GO:0060065 | uterus development(GO:0060065) |
| 0.0 | 0.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
| 0.0 | 0.2 | GO:0071493 | cellular response to UV-B(GO:0071493) |
| 0.0 | 0.1 | GO:0089700 | protein kinase D signaling(GO:0089700) |
| 0.0 | 0.6 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
| 0.0 | 0.5 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.0 | 0.5 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
| 0.0 | 1.0 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
| 0.0 | 0.6 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.0 | 0.6 | GO:0043535 | regulation of blood vessel endothelial cell migration(GO:0043535) |
| 0.0 | 0.6 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
| 0.0 | 0.3 | GO:0015747 | urate transport(GO:0015747) |
| 0.0 | 1.0 | GO:0002819 | regulation of adaptive immune response(GO:0002819) |
| 0.0 | 0.2 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.0 | 0.4 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.0 | 0.5 | GO:0006825 | copper ion transport(GO:0006825) |
| 0.0 | 0.1 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 0.0 | 0.1 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
| 0.0 | 0.3 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
| 0.0 | 0.1 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.0 | 0.1 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 0.0 | 0.3 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.0 | 1.1 | GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent(GO:0002479) |
| 0.0 | 0.2 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
| 0.0 | 0.2 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.0 | 0.5 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
| 0.0 | 0.3 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
| 0.0 | 1.8 | GO:1990823 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
| 0.0 | 0.4 | GO:0030282 | bone mineralization(GO:0030282) |
| 0.0 | 0.0 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.0 | 0.3 | GO:0003417 | growth plate cartilage development(GO:0003417) |
| 0.0 | 0.2 | GO:1900077 | negative regulation of insulin receptor signaling pathway(GO:0046627) negative regulation of cellular response to insulin stimulus(GO:1900077) |
| 0.0 | 0.2 | GO:0014029 | nucleolus organization(GO:0007000) neural crest formation(GO:0014029) |
| 0.0 | 0.3 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
| 0.0 | 0.1 | GO:0009227 | UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
| 0.0 | 0.1 | GO:0042048 | olfactory behavior(GO:0042048) |
| 0.0 | 0.1 | GO:1902745 | positive regulation of lamellipodium assembly(GO:0010592) positive regulation of lamellipodium organization(GO:1902745) |
| 0.0 | 0.1 | GO:0001821 | histamine secretion(GO:0001821) |
| 0.0 | 0.6 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
| 0.0 | 0.2 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
| 0.0 | 0.1 | GO:0072718 | response to cisplatin(GO:0072718) |
| 0.0 | 0.2 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
| 0.0 | 0.2 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
| 0.0 | 1.3 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
| 0.0 | 1.5 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
| 0.0 | 0.2 | GO:0070228 | regulation of lymphocyte apoptotic process(GO:0070228) |
| 0.0 | 0.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
| 0.0 | 0.0 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
| 0.0 | 0.1 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
| 0.0 | 0.8 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
| 0.0 | 0.6 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
| 0.0 | 0.5 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.0 | 0.1 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
| 0.0 | 0.0 | GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
| 0.0 | 0.5 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
| 0.0 | 0.2 | GO:0045667 | regulation of osteoblast differentiation(GO:0045667) |
| 0.0 | 0.4 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
| 0.0 | 0.3 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
| 0.0 | 1.3 | GO:0051017 | actin filament bundle assembly(GO:0051017) actin filament bundle organization(GO:0061572) |
| 0.0 | 0.1 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
| 0.0 | 0.1 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
| 0.0 | 0.1 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.0 | 0.8 | GO:0001837 | epithelial to mesenchymal transition(GO:0001837) |
| 0.0 | 0.3 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
| 0.0 | 0.4 | GO:0015682 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.9 | 11.1 | GO:0097486 | multivesicular body lumen(GO:0097486) |
| 0.9 | 2.6 | GO:0097679 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) other organism cytoplasm(GO:0097679) |
| 0.9 | 11.3 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
| 0.8 | 2.4 | GO:0001534 | radial spoke(GO:0001534) |
| 0.7 | 15.8 | GO:0042613 | MHC class II protein complex(GO:0042613) |
| 0.6 | 34.1 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 0.5 | 1.5 | GO:0005584 | collagen type I trimer(GO:0005584) |
| 0.4 | 1.2 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
| 0.4 | 1.2 | GO:0032783 | ELL-EAF complex(GO:0032783) |
| 0.4 | 1.5 | GO:0005607 | laminin-2 complex(GO:0005607) |
| 0.4 | 1.8 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
| 0.3 | 1.4 | GO:0031523 | Myb complex(GO:0031523) |
| 0.3 | 1.3 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
| 0.3 | 0.6 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
| 0.3 | 7.5 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 0.3 | 1.9 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
| 0.3 | 2.9 | GO:0071953 | elastic fiber(GO:0071953) |
| 0.3 | 0.8 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
| 0.2 | 2.9 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.2 | 0.8 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
| 0.2 | 1.7 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.2 | 1.2 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
| 0.2 | 0.6 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
| 0.2 | 3.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
| 0.2 | 0.7 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
| 0.2 | 0.3 | GO:0071437 | invadopodium(GO:0071437) |
| 0.2 | 0.3 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
| 0.2 | 5.6 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.2 | 9.7 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.2 | 0.9 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
| 0.2 | 0.5 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
| 0.1 | 0.9 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
| 0.1 | 22.6 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.1 | 0.3 | GO:0031906 | late endosome lumen(GO:0031906) |
| 0.1 | 1.0 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
| 0.1 | 3.9 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.1 | 1.1 | GO:0043196 | varicosity(GO:0043196) |
| 0.1 | 2.6 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.1 | 0.8 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
| 0.1 | 1.1 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
| 0.1 | 1.1 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
| 0.1 | 21.8 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.1 | 0.8 | GO:0032010 | phagolysosome(GO:0032010) |
| 0.1 | 2.4 | GO:0005605 | basal lamina(GO:0005605) |
| 0.1 | 1.1 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.1 | 0.1 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
| 0.1 | 0.7 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
| 0.1 | 0.5 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
| 0.1 | 0.6 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 0.1 | 2.4 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
| 0.1 | 2.8 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.1 | 0.4 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 0.1 | 0.2 | GO:0098844 | postsynaptic endocytic zone membrane(GO:0098844) |
| 0.1 | 1.0 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 0.1 | 0.7 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
| 0.1 | 1.0 | GO:0044853 | plasma membrane raft(GO:0044853) |
| 0.1 | 0.6 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
| 0.1 | 1.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.1 | 0.4 | GO:0031905 | early endosome lumen(GO:0031905) |
| 0.1 | 9.6 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.1 | 0.3 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
| 0.1 | 1.0 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 0.1 | 3.9 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.1 | 0.6 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.1 | 0.8 | GO:1990909 | Wnt signalosome(GO:1990909) |
| 0.1 | 0.2 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
| 0.1 | 0.8 | GO:0036157 | outer dynein arm(GO:0036157) |
| 0.1 | 0.1 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.1 | 5.9 | GO:0005902 | microvillus(GO:0005902) |
| 0.1 | 0.1 | GO:0097209 | epidermal lamellar body(GO:0097209) |
| 0.1 | 0.2 | GO:1903095 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
| 0.1 | 0.7 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
| 0.1 | 1.3 | GO:0097342 | ripoptosome(GO:0097342) |
| 0.1 | 0.9 | GO:0033093 | Weibel-Palade body(GO:0033093) |
| 0.0 | 1.5 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
| 0.0 | 1.7 | GO:0000145 | exocyst(GO:0000145) |
| 0.0 | 1.1 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
| 0.0 | 0.4 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
| 0.0 | 0.5 | GO:0030478 | actin cap(GO:0030478) |
| 0.0 | 1.5 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.0 | 1.3 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.0 | 0.5 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.0 | 6.0 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 0.0 | 8.9 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
| 0.0 | 1.3 | GO:0009925 | basal plasma membrane(GO:0009925) |
| 0.0 | 0.3 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 0.0 | 12.4 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.0 | 0.4 | GO:0031430 | M band(GO:0031430) |
| 0.0 | 72.7 | GO:0005615 | extracellular space(GO:0005615) |
| 0.0 | 0.9 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.0 | 0.8 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.0 | 0.6 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 0.0 | 0.5 | GO:0008091 | spectrin(GO:0008091) |
| 0.0 | 0.5 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.0 | 2.1 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.0 | 2.5 | GO:0035577 | azurophil granule membrane(GO:0035577) |
| 0.0 | 0.1 | GO:0034706 | sodium channel complex(GO:0034706) |
| 0.0 | 0.7 | GO:0031012 | extracellular matrix(GO:0031012) |
| 0.0 | 6.7 | GO:0001650 | fibrillar center(GO:0001650) |
| 0.0 | 0.2 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
| 0.0 | 8.9 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
| 0.0 | 1.1 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
| 0.0 | 0.8 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
| 0.0 | 0.7 | GO:0031932 | TORC2 complex(GO:0031932) |
| 0.0 | 0.9 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 0.0 | 0.2 | GO:0008278 | cohesin complex(GO:0008278) |
| 0.0 | 0.6 | GO:0042734 | presynaptic membrane(GO:0042734) |
| 0.0 | 0.7 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
| 0.0 | 0.6 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
| 0.0 | 0.4 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.0 | 0.3 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
| 0.0 | 0.9 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
| 0.0 | 1.3 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.0 | 0.4 | GO:0036038 | MKS complex(GO:0036038) |
| 0.0 | 0.4 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
| 0.0 | 1.4 | GO:0030667 | secretory granule membrane(GO:0030667) |
| 0.0 | 1.6 | GO:0035578 | azurophil granule lumen(GO:0035578) |
| 0.0 | 0.2 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.0 | 0.0 | GO:0035101 | FACT complex(GO:0035101) |
| 0.0 | 0.2 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.0 | 0.5 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
| 0.0 | 0.4 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.0 | 2.3 | GO:0005815 | microtubule organizing center(GO:0005815) |
| 0.0 | 0.3 | GO:0044232 | organelle membrane contact site(GO:0044232) |
| 0.0 | 6.3 | GO:0005769 | early endosome(GO:0005769) |
| 0.0 | 0.3 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
| 0.0 | 2.7 | GO:0034774 | secretory granule lumen(GO:0034774) |
| 0.0 | 0.3 | GO:0016459 | myosin complex(GO:0016459) |
| 0.0 | 0.2 | GO:0000788 | nuclear nucleosome(GO:0000788) |
| 0.0 | 1.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.0 | 0.5 | GO:0005876 | spindle microtubule(GO:0005876) |
| 0.0 | 0.9 | GO:0043195 | terminal bouton(GO:0043195) |
| 0.0 | 1.3 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.0 | 1.4 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.0 | 0.4 | GO:0097228 | sperm principal piece(GO:0097228) |
| 0.0 | 0.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.0 | 0.5 | GO:0000795 | synaptonemal complex(GO:0000795) |
| 0.0 | 0.3 | GO:0044295 | axonal growth cone(GO:0044295) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.7 | 6.9 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
| 1.6 | 6.2 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
| 1.0 | 16.8 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
| 0.8 | 3.1 | GO:0052593 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
| 0.7 | 6.6 | GO:0042610 | CD8 receptor binding(GO:0042610) |
| 0.7 | 5.5 | GO:0032396 | inhibitory MHC class I receptor activity(GO:0032396) |
| 0.7 | 2.6 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
| 0.6 | 1.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.6 | 3.6 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.6 | 6.4 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
| 0.6 | 2.3 | GO:0036134 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
| 0.6 | 2.2 | GO:0005018 | platelet-derived growth factor alpha-receptor activity(GO:0005018) |
| 0.6 | 145.9 | GO:0003823 | antigen binding(GO:0003823) |
| 0.6 | 2.2 | GO:0061714 | folic acid receptor activity(GO:0061714) |
| 0.5 | 4.7 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
| 0.5 | 2.4 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
| 0.5 | 4.6 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.5 | 2.3 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
| 0.4 | 1.3 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
| 0.4 | 3.5 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
| 0.4 | 1.3 | GO:0042007 | interleukin-18 binding(GO:0042007) |
| 0.4 | 1.2 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
| 0.4 | 3.2 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
| 0.4 | 1.2 | GO:0008520 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
| 0.4 | 11.6 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.4 | 2.6 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
| 0.3 | 1.0 | GO:0086078 | gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling(GO:0086076) gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling(GO:0086078) gap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical coupling(GO:0086079) |
| 0.3 | 2.3 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
| 0.3 | 2.2 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
| 0.3 | 1.0 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
| 0.3 | 1.9 | GO:0070699 | type II activin receptor binding(GO:0070699) |
| 0.3 | 8.5 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.3 | 1.5 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
| 0.3 | 4.7 | GO:0019864 | IgG binding(GO:0019864) |
| 0.3 | 0.8 | GO:0042289 | MHC class II protein binding(GO:0042289) |
| 0.3 | 1.6 | GO:0050436 | microfibril binding(GO:0050436) |
| 0.3 | 0.3 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
| 0.3 | 0.8 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
| 0.3 | 10.8 | GO:0017147 | Wnt-protein binding(GO:0017147) |
| 0.2 | 1.2 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 0.2 | 0.7 | GO:0033867 | Fas-activated serine/threonine kinase activity(GO:0033867) |
| 0.2 | 1.0 | GO:0016263 | glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity(GO:0016263) |
| 0.2 | 1.5 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
| 0.2 | 1.0 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
| 0.2 | 0.7 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
| 0.2 | 0.7 | GO:0005055 | laminin receptor activity(GO:0005055) |
| 0.2 | 1.8 | GO:0017046 | peptide hormone binding(GO:0017046) |
| 0.2 | 1.3 | GO:0030492 | hemoglobin binding(GO:0030492) |
| 0.2 | 0.9 | GO:0003978 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
| 0.2 | 1.9 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 0.2 | 1.0 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
| 0.2 | 1.0 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
| 0.2 | 3.7 | GO:0008199 | ferric iron binding(GO:0008199) |
| 0.2 | 1.4 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
| 0.2 | 3.0 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.2 | 0.5 | GO:0031877 | somatostatin receptor binding(GO:0031877) |
| 0.2 | 2.2 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 0.2 | 1.8 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 0.2 | 0.8 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 0.2 | 3.2 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
| 0.2 | 0.8 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
| 0.2 | 0.8 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
| 0.2 | 0.6 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.2 | 0.8 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
| 0.2 | 0.6 | GO:0033823 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
| 0.2 | 1.5 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.2 | 0.5 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
| 0.2 | 1.7 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.1 | 1.3 | GO:0032810 | sterol response element binding(GO:0032810) |
| 0.1 | 0.9 | GO:0004918 | interleukin-8 receptor activity(GO:0004918) |
| 0.1 | 0.4 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
| 0.1 | 1.3 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 0.1 | 1.6 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 0.1 | 1.9 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.1 | 0.4 | GO:0071633 | dihydroceramidase activity(GO:0071633) |
| 0.1 | 0.4 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
| 0.1 | 1.0 | GO:0008481 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
| 0.1 | 1.4 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
| 0.1 | 0.6 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
| 0.1 | 0.4 | GO:0015361 | low-affinity sodium:dicarboxylate symporter activity(GO:0015361) |
| 0.1 | 1.0 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
| 0.1 | 0.6 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
| 0.1 | 3.8 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 0.1 | 1.1 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
| 0.1 | 2.5 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
| 0.1 | 0.9 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 0.1 | 1.5 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 0.1 | 2.6 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.1 | 0.5 | GO:0019862 | IgA binding(GO:0019862) |
| 0.1 | 1.0 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
| 0.1 | 0.3 | GO:0097001 | ceramide binding(GO:0097001) |
| 0.1 | 0.6 | GO:0035326 | enhancer binding(GO:0035326) |
| 0.1 | 0.8 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 0.1 | 0.6 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 0.1 | 0.4 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
| 0.1 | 2.5 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
| 0.1 | 4.8 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.1 | 2.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 0.1 | 1.1 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.1 | 2.4 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
| 0.1 | 1.7 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
| 0.1 | 0.7 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
| 0.1 | 7.9 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
| 0.1 | 1.0 | GO:0045545 | syndecan binding(GO:0045545) |
| 0.1 | 0.5 | GO:0031751 | D4 dopamine receptor binding(GO:0031751) |
| 0.1 | 0.6 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
| 0.1 | 3.2 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
| 0.1 | 0.4 | GO:0035651 | AP-1 adaptor complex binding(GO:0035650) AP-3 adaptor complex binding(GO:0035651) |
| 0.1 | 0.4 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
| 0.1 | 1.6 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.1 | 0.2 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) |
| 0.1 | 1.2 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
| 0.1 | 0.3 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 0.1 | 3.0 | GO:0042056 | chemoattractant activity(GO:0042056) |
| 0.1 | 0.7 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.1 | 0.9 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
| 0.1 | 6.2 | GO:0005044 | scavenger receptor activity(GO:0005044) |
| 0.1 | 1.1 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.1 | 0.3 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
| 0.1 | 0.4 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
| 0.1 | 1.2 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
| 0.1 | 0.3 | GO:0008443 | phosphofructokinase activity(GO:0008443) |
| 0.1 | 0.6 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) TPR domain binding(GO:0030911) |
| 0.1 | 0.5 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
| 0.1 | 0.6 | GO:0015057 | thrombin receptor activity(GO:0015057) |
| 0.1 | 0.8 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
| 0.1 | 2.5 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
| 0.1 | 1.5 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
| 0.1 | 0.3 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.1 | 0.5 | GO:0005119 | smoothened binding(GO:0005119) |
| 0.1 | 0.9 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
| 0.1 | 2.3 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.1 | 2.1 | GO:0031005 | filamin binding(GO:0031005) |
| 0.1 | 6.5 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
| 0.1 | 3.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.1 | 1.2 | GO:0005537 | mannose binding(GO:0005537) |
| 0.1 | 0.6 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.1 | 1.8 | GO:0048018 | receptor agonist activity(GO:0048018) |
| 0.1 | 1.0 | GO:0017022 | myosin binding(GO:0017022) |
| 0.1 | 3.0 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.1 | 0.2 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
| 0.1 | 1.8 | GO:0070403 | NAD+ binding(GO:0070403) |
| 0.1 | 0.7 | GO:0033691 | sialic acid binding(GO:0033691) |
| 0.1 | 0.3 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
| 0.1 | 0.3 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
| 0.1 | 3.3 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.1 | 0.8 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
| 0.1 | 0.8 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
| 0.1 | 0.7 | GO:0042834 | peptidoglycan binding(GO:0042834) |
| 0.1 | 1.4 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.1 | 0.9 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.1 | 1.0 | GO:0030957 | Tat protein binding(GO:0030957) |
| 0.1 | 0.4 | GO:0031849 | olfactory receptor binding(GO:0031849) |
| 0.1 | 2.2 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.1 | 0.7 | GO:0036310 | annealing helicase activity(GO:0036310) |
| 0.1 | 1.8 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 0.1 | 0.5 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) neurotrophin receptor activity(GO:0005030) |
| 0.1 | 1.0 | GO:0019841 | retinol binding(GO:0019841) |
| 0.1 | 0.6 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 0.1 | 0.5 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.0 | 0.1 | GO:0038131 | neuregulin receptor activity(GO:0038131) |
| 0.0 | 1.2 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
| 0.0 | 1.2 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 0.0 | 0.2 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
| 0.0 | 1.6 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.0 | 1.3 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.0 | 0.6 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
| 0.0 | 0.4 | GO:0005113 | patched binding(GO:0005113) |
| 0.0 | 0.6 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
| 0.0 | 0.3 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 0.0 | 0.3 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
| 0.0 | 0.9 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
| 0.0 | 0.5 | GO:0030620 | U2 snRNA binding(GO:0030620) |
| 0.0 | 0.3 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
| 0.0 | 0.2 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
| 0.0 | 0.1 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
| 0.0 | 1.4 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
| 0.0 | 0.7 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
| 0.0 | 1.3 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
| 0.0 | 0.6 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
| 0.0 | 0.8 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.0 | 0.6 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
| 0.0 | 0.9 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
| 0.0 | 0.1 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
| 0.0 | 0.5 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.0 | 13.7 | GO:0030246 | carbohydrate binding(GO:0030246) |
| 0.0 | 1.4 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 0.0 | 1.1 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
| 0.0 | 1.4 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.0 | 2.2 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
| 0.0 | 0.3 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
| 0.0 | 0.2 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.0 | 0.2 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
| 0.0 | 0.4 | GO:0045159 | myosin II binding(GO:0045159) |
| 0.0 | 0.6 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 0.0 | 0.5 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.0 | 0.5 | GO:0048185 | activin binding(GO:0048185) |
| 0.0 | 0.4 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
| 0.0 | 0.1 | GO:0051499 | D-aminoacyl-tRNA deacylase activity(GO:0051499) D-tyrosyl-tRNA(Tyr) deacylase activity(GO:0051500) |
| 0.0 | 0.3 | GO:0005003 | ephrin receptor activity(GO:0005003) |
| 0.0 | 0.4 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.0 | 0.2 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
| 0.0 | 0.5 | GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) |
| 0.0 | 0.3 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 0.0 | 0.2 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
| 0.0 | 0.8 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 0.0 | 0.8 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.0 | 1.0 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.0 | 0.6 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.0 | 1.3 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
| 0.0 | 0.2 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
| 0.0 | 0.2 | GO:0042731 | PH domain binding(GO:0042731) |
| 0.0 | 0.4 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 0.0 | 1.0 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.0 | 0.5 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
| 0.0 | 2.3 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.0 | 0.1 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
| 0.0 | 0.5 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 0.0 | 0.9 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.0 | 0.2 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
| 0.0 | 0.3 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
| 0.0 | 0.3 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
| 0.0 | 0.2 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
| 0.0 | 10.4 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
| 0.0 | 0.4 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.0 | 0.1 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.0 | 0.7 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 0.0 | 0.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.0 | 0.8 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.0 | 0.3 | GO:0045503 | dynein light chain binding(GO:0045503) |
| 0.0 | 0.1 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
| 0.0 | 0.5 | GO:0005523 | tropomyosin binding(GO:0005523) |
| 0.0 | 0.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.0 | 0.7 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.0 | 0.2 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
| 0.0 | 0.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.0 | 0.5 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.0 | 0.4 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.0 | 0.1 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
| 0.0 | 0.4 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 0.0 | 2.6 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.0 | 0.4 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 0.0 | 0.0 | GO:0050577 | GDP-4-dehydro-D-rhamnose reductase activity(GO:0042356) GDP-L-fucose synthase activity(GO:0050577) |
| 0.0 | 0.1 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.0 | 0.3 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
| 0.0 | 0.4 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
| 0.0 | 0.8 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
| 0.0 | 0.2 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
| 0.0 | 0.1 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
| 0.0 | 1.1 | GO:0035064 | methylated histone binding(GO:0035064) |
| 0.0 | 0.2 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 0.0 | 0.3 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
| 0.0 | 0.1 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.0 | 2.6 | GO:0001664 | G-protein coupled receptor binding(GO:0001664) |
| 0.0 | 0.1 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
| 0.0 | 0.3 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 0.0 | 0.2 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
| 0.0 | 0.1 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.0 | 0.1 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 0.0 | 0.2 | GO:0015250 | water channel activity(GO:0015250) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.4 | 5.2 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
| 0.2 | 3.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 0.2 | 13.3 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
| 0.2 | 12.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.2 | 4.5 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 0.1 | 5.9 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.1 | 4.6 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.1 | 3.9 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.1 | 18.0 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
| 0.1 | 3.8 | PID S1P S1P1 PATHWAY | S1P1 pathway |
| 0.1 | 0.7 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 0.1 | 11.4 | PID IL4 2PATHWAY | IL4-mediated signaling events |
| 0.1 | 3.7 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
| 0.1 | 1.8 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
| 0.1 | 4.2 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.1 | 22.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.1 | 1.5 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.1 | 1.6 | PID IL27 PATHWAY | IL27-mediated signaling events |
| 0.1 | 1.9 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.1 | 0.7 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.1 | 1.4 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
| 0.1 | 0.6 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
| 0.1 | 7.5 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.1 | 2.7 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
| 0.1 | 2.6 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
| 0.1 | 1.4 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
| 0.1 | 0.7 | PID IL23 PATHWAY | IL23-mediated signaling events |
| 0.1 | 3.0 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 0.1 | 0.9 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
| 0.0 | 6.9 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
| 0.0 | 1.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.0 | 14.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.0 | 0.8 | PID REELIN PATHWAY | Reelin signaling pathway |
| 0.0 | 0.5 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.0 | 1.9 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.0 | 4.5 | PID CMYB PATHWAY | C-MYB transcription factor network |
| 0.0 | 0.6 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 0.0 | 3.1 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.0 | 2.5 | PID CDC42 PATHWAY | CDC42 signaling events |
| 0.0 | 4.3 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 0.0 | 0.8 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.0 | 1.1 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
| 0.0 | 0.9 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.0 | 1.0 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.0 | 0.8 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.0 | 0.5 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.0 | 0.5 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
| 0.0 | 0.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
| 0.0 | 0.9 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.0 | 0.4 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
| 0.0 | 1.1 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
| 0.0 | 0.6 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.0 | 0.5 | PID SHP2 PATHWAY | SHP2 signaling |
| 0.0 | 0.8 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
| 0.0 | 0.4 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
| 0.0 | 0.3 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 0.0 | 0.5 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 0.0 | 1.1 | PID PLK1 PATHWAY | PLK1 signaling events |
| 0.0 | 5.3 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
| 0.0 | 0.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.0 | 1.5 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
| 0.0 | 0.4 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.0 | 0.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.0 | 1.0 | PID AP1 PATHWAY | AP-1 transcription factor network |
| 0.0 | 0.6 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
| 0.0 | 0.4 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
| 0.0 | 0.6 | PID BMP PATHWAY | BMP receptor signaling |
| 0.0 | 0.3 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 0.0 | 0.4 | PID BARD1 PATHWAY | BARD1 signaling events |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.8 | 21.2 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
| 0.4 | 5.6 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
| 0.3 | 4.5 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
| 0.2 | 4.5 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
| 0.2 | 3.6 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
| 0.2 | 6.4 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
| 0.2 | 12.5 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.2 | 5.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.1 | 8.9 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
| 0.1 | 2.5 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
| 0.1 | 2.0 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 0.1 | 1.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
| 0.1 | 3.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.1 | 2.6 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.1 | 10.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.1 | 2.2 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
| 0.1 | 1.9 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
| 0.1 | 0.8 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
| 0.1 | 2.6 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.1 | 2.6 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.1 | 1.0 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.1 | 2.9 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
| 0.1 | 1.2 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
| 0.1 | 2.5 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 0.1 | 6.0 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
| 0.1 | 2.2 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.1 | 5.4 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.0 | 2.7 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
| 0.0 | 0.8 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
| 0.0 | 2.8 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
| 0.0 | 0.9 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
| 0.0 | 0.8 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
| 0.0 | 2.0 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
| 0.0 | 0.7 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
| 0.0 | 2.0 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
| 0.0 | 0.8 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
| 0.0 | 3.0 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.0 | 3.6 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.0 | 1.1 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.0 | 4.4 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.0 | 1.0 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
| 0.0 | 1.9 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
| 0.0 | 1.4 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
| 0.0 | 1.7 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
| 0.0 | 0.1 | REACTOME MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | Genes involved in MAPK targets/ Nuclear events mediated by MAP kinases |
| 0.0 | 0.2 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
| 0.0 | 0.6 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
| 0.0 | 0.6 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
| 0.0 | 1.8 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.0 | 0.7 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.0 | 2.7 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.0 | 0.8 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.0 | 0.6 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.0 | 0.4 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.0 | 0.5 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
| 0.0 | 0.4 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
| 0.0 | 3.6 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
| 0.0 | 0.6 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
| 0.0 | 2.5 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.0 | 0.4 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.0 | 0.4 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.0 | 0.3 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 0.0 | 0.5 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.0 | 0.2 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
| 0.0 | 0.5 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 0.0 | 0.4 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 0.0 | 0.9 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.0 | 0.5 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 0.0 | 1.0 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.0 | 0.6 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
| 0.0 | 0.2 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
| 0.0 | 0.8 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
| 0.0 | 2.3 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
| 0.0 | 1.5 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 0.0 | 1.7 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
| 0.0 | 0.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.0 | 0.4 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 0.0 | 1.9 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
| 0.0 | 0.3 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.0 | 0.3 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.0 | 0.4 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
| 0.0 | 0.2 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |